New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For BA;AMZN;RIMM;BBRY;CHK;ENDP;BIOC;CPNO;KMP;MTOR;HA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
March 16, 2015
16:00 EDTAMZNOptions Update; March 16, 2015
Subscribe for More Information
13:37 EDTBABoeing responds to IAM's petition to unionize Boeing South Carolina
Boeing was notified that the International Association of Machinists union has petitioned the National Labor Relations Board for a union election at the company's North Charleston, S.C., facilities. If the NLRB permits it, a vote will be scheduled for eligible teammates to decide whether they will turn over their rights to the IAM or keep a direct relationship with the company. "Boeing South Carolina teammates have done what so many people said couldn't be done. And they did it by working together, engaging every day, and truly committing themselves to the success of our site," said Beverly Wyse, Boeing South Carolina's newly appointed vice president and general manager. "And let's be really clear, the IAM was not part of this success – it was our BSC teammates. In fact, the IAM aggressively opposed it, as publicly demonstrated by their filing of a claim with the National Labor Relations Board, to try to keep our site from even opening. Now, simply by filing this petition, the same union that tried to take our jobs and our work, has already begun to divide our team at a time when we're just beginning to gel and catch a solid rhythm in production." Boeing firmly believes that a union is not in the best interest of Boeing South Carolina teammates and their families, their communities, and the state of South Carolina, especially after years of the IAM insulting the abilities of Boeing South Carolina teammates and fighting against BSC's success. "We think our Boeing South Carolina teammates deserve to pave their own future and keep their hard-earned money in their own pockets," said Wyse. "In fact, they've been very successful doing just that for the past five years. They've built not only new airplanes, but also a new site, and new opportunities for an incredible future here in South Carolina by working together as a team, without the distractions of a union. We're extremely proud of what our teammates have accomplished." Boeing South Carolina has established several outlets to keep teammates, their families and the community updated throughout this process, including a website and Facebook page that provides information, facts, data, and additional resources related to the IAM's unionizing efforts in South Carolina.
12:43 EDTENDPOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday after stimulus talk out of China and a rally in European stock markets lifted the U.S. market at the open. There was little reaction to the day’s domestic economic reports, which included the Empire manufacturing index, industrial production data, and a homebuilder confidence index. The week's big economic news, however, is yet to come, as investors look forward to the conclusion of the Federal Reserve's latest rate setting meeting on Wednesday. ECONOMIC EVENTS: In the U.S., the Empire State manufacturing index dipped to 6.9 in March, versus the consensus forecast for a reading of 8.0. Industrial production edged up 0.1% in February, versus expectations for an increase of 0.2%, and capacity utilization fell to 78.9%, versus the 79.5% consensus forecast. The NAHB homebuilder sentiment index dropped to 53 in March from 55 in February, missing expectation for the index to rise to 56. Oil prices continued to tumble, with U.S. crude dropping to a six-year low below $44 per barrel earlier in the session. In Asia, Chinese Premier Li Keqiang said Sunday that his government has room and the tools to take action should growth falter, without detailing specific remedies the government might pursue. COMPANY NEWS: Valeant (VRX), which not long ago lost out to Actavis (ACT) in the race to buy Allergan (AGN), increased its chances of making sure its latest buyout deal gets done by increasing its takeover offer to Salix Pharmaceuticals (SLXP) by about $1B. Rival bidder Endo Health (ENDP) confirmed that it is withdrawing its cash and stock proposal to acquire Salix after Valeant raised its all-cash bid for Salix to $173 per share from $158 per share. Shares of Valeant and Salix both rose about 2%, while Endo shares gained 2.5% following the announcements. MAJOR MOVERS: Among the notable gainers was Life Time Fitness (LTM), which rose 5% after entering into a definitive agreement to be acquired by private equity firms Leonard Green & Partners and TPG in a transaction valued at more than $4B, or $72.10 per share, in cash. Also higher was Edwards Lifesciences (EW), which rose 8% after the company reported data at this weekend's American College of Cardiology conference. Among the noteworthy losers was iDreamSky (DSKY), which dropped more than 25% after the company lowered its guidance because the launch of a popular casual game was delayed on one of the company distribution platforms and the monetization of another popular casual game was less than expected. Also lower were shares of Enzo Biochem (ENZ), which fell 17% after an appeals court reversed-in-part and vacated-in-part the judgment in Enzo’s favor that Life Technologies' (LIFE) Applera Corp. infringed certain Enzo patents. INDEXES: Near midday, the Dow was up 174.81, or 0.98%, to 17,924.12, the Nasdaq was up 39.80, or 0.82%, to 4,911.55, and the S&P 500 was up 20.07, or 0.98%, to 2,073.47.
11:20 EDTBBRYStocks with call strike movement; MNKD BBRY
Subscribe for More Information
10:58 EDTENDPValeant price hike likely ends Salix saga, says UBS
UBS believes the race for Salix (SLXP) is likely over now that Valeant (VRX) has increased its offer price, as expected. The firm said it will still like both Valeant (VRX) and Endo (ENDP) if this is how things end, as it believes the deal is still a very good one for Valeant despite the higher price and it expects Endo to find another deal that should be accretive. UBS has Buy ratings on both Valeant and Endo Health.
10:44 EDTAMZNNetflix retreats after cut to sell on competition, cost concerns
The shares of Netflix (NFLX) are falling after research firm Evercore ISI downgraded the stock to Sell from Hold. Increased competition will force the company to increase its investments and the return from those investments is uncertain, the firm contends. WHAT'S NEW: In the U.S., technological advancements are enabling content providers to sell their programming to a wider range of Internet video distributors, Evercore ISI analyst Ken Sena wrote in a note to investors earlier today. Moreover, content providers themselves are now able to stream more of their programming online and obtain higher profits from doing so, Sena reported. The analyst noted that Apple (AAPL) recently obtained a three month exclusive deal to stream content form Time Warner's (TWX) HBO Now, while Yahoo (YHOO), Amazon (AMZN), and Hulu (DIS, CMCSA, NWSA) are all reportedly interested in obtaining streaming rights to "Seinfeld." Netflix's international expansion will not be sufficient to offset the increased competition, especially because foreign viewers are likely to watch less TV and be less interested in paying for TV content, the analyst believes. Furthermore, Netflix will face more competition from other Internet TV services overseas than in the U.S., according to Sena, who cut his 2015 consolidated operating income estimate for the company by 26% to $381M from $517M previously. In addition to cutting his rating, Sena lowered his price target on the shares to $380 from $450. PRICE ACTION: In early trading, Netflix sank $16, or 3.7%, to $422.
10:18 EDTENDPValeant should win Salix with increased offer, says Cantor
Subscribe for More Information
10:00 EDTBARyanair plans transatlantic service in four to five years, Financial Times says
Subscribe for More Information
09:24 EDTENDPEndo withdraws proposal for Salix
Subscribe for More Information
09:11 EDTBAViaSat and Boeing announce collaboration to offer broadband system
Subscribe for More Information
08:17 EDTENDPValeant rises 1% after sweetening Salix takeover offer
Subscribe for More Information
08:06 EDTENDPValeant ses Salix deal closing on April 1
08:05 EDTENDPValeant raises offer price for Salix to $173 per share from $158
Subscribe for More Information
07:50 EDTENDPValeant to raise offer for Salix to $173 per share, DJ reports
Dow Jones cites sources.
07:31 EDTENDPEndo announces launch of Natesto
Endo Pharmaceuticals, a subsidiary of Endo, announced the commercial availability of NATESTO, the first and only nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism. NATESTO was approved by the FDA in May 2014 for replacement therapy in adult men with conditions associated with deficiency or absence of endogenous testosterone, including primary hypogonadism or hypogonadotropic hypogonadism. NATESTO™ reduces the risk of transference via intranasal application.
06:59 EDTBABoeing to hit 737 production targets by 2018, Reuters says
Subscribe for More Information
06:07 EDTBBRYStocks with implied volatility above IV index mean; BBRY CZR
Subscribe for More Information
March 15, 2015
16:14 EDTBBRYBlackBerry collaborates with IBM, Samsung on SecuTABLET
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use